Clinical trial
Evaluation of Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen…
NCT00109759 · Allergy Therapeutics, Industry · Withdrawn
Key facts
| NCT number | NCT00109759 |
|---|---|
| Title | Evaluation of Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL (Monophosphoryl Lipid A) |
| Official title | A Double-Blind Phase I Study to Evaluate the Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL® in Healthy Volunteers. |
| Lead sponsor | Allergy Therapeutics, Industry |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Type I Hypersensitivity |
| Intervention type | Biological, Drug |
| Interventions | RagweedMATAMPL, Placebo |
| Enrollment | 0 |
| Start date | May 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | May 4, 2005 |
| Last update posted | Aug 12, 2021 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: